CLINICIAN AWARENESS, ATTITUDES, AND INTEREST IN BLOOD TESTS FOR ALZHEIMER’S DISEASE
Karen Tracy, Julie Wood, Ben Tiede, Emily Scholler · 2024
Read CLINICIAN AWARENESS, ATTITUDES, AND INTEREST IN BLOOD TESTS FOR ALZHEIMER’S DISEASE by Karen Tracy, Julie Wood, Ben Tiede, Emily Scholler (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11691828.txt.
Description
Karen Tracy and co-authors survey clinicians on blood tests for Alzheimer's disease, in work from twenty twenty-four. Blood based markers of amyloid and tau could make diagnosis faster and cheaper than brain scans or spinal fluid tests. A global initiative is preparing clinics for wide use of such tests.
Family doctor and aging society members answered surveys in spring twenty twenty-four. They shared current awareness of the tests, views on their value, and how they might use them in practice. They also named what they need to trust the tests: more knowledge and clearer guidance. Early detection matters since timely diagnosis still lags in clinics. The results guide training for the roll out.
Catalog record
| CREATOR | Karen Tracy, Julie Wood, Ben Tiede, Emily Scholler |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 1 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |